Real-world Efficacy Data on Anti-Angiogenic Drugs in Recurrent Small Cell Cervical Carcinoma: A Retrospective Study

OBJECTIVE: Small cell carcinoma of the cervix (SCCC) is rare but extremely aggressive and resistant to current therapies. We herein evaluate the efficacy of bevacizumab, apatinib, and anlotinib in recurrent/metastatic SCCC patients in a real-world setting. METHODS: Recurrent/metastatic SCCC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Haifeng, Su, Ning, Yan, Shuping, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996736/
https://www.ncbi.nlm.nih.gov/pubmed/36883253
http://dx.doi.org/10.1177/15330338231160393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996736/
https://www.ncbi.nlm.nih.gov/pubmed/36883253
http://dx.doi.org/10.1177/15330338231160393

Ejemplares similares